SRR26320083
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- SPERMATOGENESIS+0.430
- PANCREAS_BETA_CELLS+0.400
- KRAS_SIGNALING_DN+0.230
- BILE_ACID_METABOLISM+0.080
- E2F_TARGETS-0.170
- INFLAMMATORY_RESPONSE-0.190
- ALLOGRAFT_REJECTION-0.200
- HEDGEHOG_SIGNALING-0.230
- KRAS_SIGNALING_UP-0.240
- COAGULATION-0.270
Top 10 suppressed
- MYC_TARGETS_V1-0.570
- PROTEIN_SECRETION-0.540
- TGF_BETA_SIGNALING-0.540
- INTERFERON_ALPHA_RESPONSE-0.530
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.520
- APOPTOSIS-0.500
- UNFOLDED_PROTEIN_RESPONSE-0.500
- INTERFERON_GAMMA_RESPONSE-0.480
- NOTCH_SIGNALING-0.480
- ANDROGEN_RESPONSE-0.470
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR26320081 | — | — | 0.974 |
| 2 | SRR13311179 | — | — | 0.973 |
| 3 | ERR4976608 | — | D | 0.967 |
| 4 | SRR8943038 | — | — | 0.963 |
| 5 | ERR4976605 | — | D | 0.960 |
| 6 | SRR11296798 | — | — | 0.959 |
| 7 | SRR8942981 | — | — | 0.953 |
| 8 | SRR4195666 | — | — | 0.952 |
| 9 | SRR12202440 | — | — | 0.952 |
| 10 | c7d31245-5d71-4a23-8a33-4f83c4718e20 | — | — | 0.952 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 4 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| SPERMATOGENESIS | 0.430 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.400 | Cobimetinib | — uncovered |
| KRAS_SIGNALING_DN | 0.230 | Remibrutinib | — uncovered |
| BILE_ACID_METABOLISM | 0.080 | Inavolisib | — uncovered |